協和キリンの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2015/07/14 | 1,733 | 1,759 | 1,727 | 1,746 | +38 | +2.2% | 1,476,000 |
| 2015/07/13 | 1,677 | 1,712 | 1,677 | 1,708 | +49 | +3% | 1,986,000 |
| 2015/07/10 | 1,611 | 1,677 | 1,600 | 1,659 | +110 | +7.1% | 3,243,000 |
| 2015/07/09 | 1,520 | 1,553 | 1,497 | 1,549 | -9 | -0.6% | 1,383,000 |
| 2015/07/08 | 1,600 | 1,607 | 1,557 | 1,558 | -54 | -3.3% | 1,233,000 |
| 2015/07/07 | 1,639 | 1,651 | 1,605 | 1,612 | -26 | -1.6% | 1,666,000 |
| 2015/07/06 | 1,624 | 1,657 | 1,622 | 1,638 | -26 | -1.6% | 1,456,000 |
| 2015/07/03 | 1,639 | 1,673 | 1,639 | 1,664 | +36 | +2.2% | 855,000 |
| 2015/07/02 | 1,618 | 1,642 | 1,618 | 1,628 | +31 | +1.9% | 822,000 |
| 2015/07/01 | 1,617 | 1,617 | 1,577 | 1,597 | -4 | -0.2% | 1,150,000 |
| 2015/06/30 | 1,604 | 1,623 | 1,593 | 1,601 | -11 | -0.7% | 1,091,000 |
| 2015/06/29 | 1,646 | 1,646 | 1,608 | 1,612 | -57 | -3.4% | 1,291,000 |
| 2015/06/26 | 1,678 | 1,687 | 1,653 | 1,669 | -15 | -0.9% | 1,226,000 |
| 2015/06/25 | 1,700 | 1,706 | 1,682 | 1,684 | -27 | -1.6% | 1,061,000 |
| 2015/06/24 | 1,734 | 1,737 | 1,701 | 1,711 | +4 | +0.2% | 1,169,000 |
| 2015/06/23 | 1,684 | 1,709 | 1,671 | 1,707 | +35 | +2.1% | 1,156,000 |
| 2015/06/22 | 1,649 | 1,678 | 1,640 | 1,672 | +15 | +0.9% | 1,060,000 |
| 2015/06/19 | 1,690 | 1,703 | 1,649 | 1,657 | -11 | -0.7% | 1,750,000 |
| 2015/06/18 | 1,676 | 1,682 | 1,662 | 1,668 | -14 | -0.8% | 939,000 |
| 2015/06/17 | 1,687 | 1,687 | 1,662 | 1,682 | +5 | +0.3% | 790,000 |
| 2015/06/16 | 1,672 | 1,684 | 1,662 | 1,677 | -3 | -0.2% | 844,000 |
| 2015/06/15 | 1,689 | 1,689 | 1,662 | 1,680 | -10 | -0.6% | 787,000 |
| 2015/06/12 | 1,716 | 1,719 | 1,680 | 1,690 | ±0 | ±0% | 2,688,000 |
| 2015/06/11 | 1,658 | 1,692 | 1,654 | 1,690 | +43 | +2.6% | 1,359,000 |
| 2015/06/10 | 1,640 | 1,671 | 1,637 | 1,647 | +25 | +1.5% | 1,959,000 |
| 2015/06/09 | 1,630 | 1,648 | 1,621 | 1,622 | -22 | -1.3% | 1,827,000 |
| 2015/06/08 | 1,616 | 1,647 | 1,615 | 1,644 | +34 | +2.1% | 1,957,000 |
| 2015/06/05 | 1,596 | 1,612 | 1,583 | 1,610 | +28 | +1.8% | 1,583,000 |
| 2015/06/04 | 1,594 | 1,619 | 1,580 | 1,582 | +1 | +0.1% | 1,375,000 |
| 2015/06/03 | 1,570 | 1,586 | 1,565 | 1,581 | -7 | -0.4% | 1,081,000 |
| 2015/06/02 | 1,575 | 1,610 | 1,575 | 1,588 | +1 | +0.1% | 1,183,000 |
| 2015/06/01 | 1,555 | 1,594 | 1,527 | 1,587 | +18 | +1.1% | 1,868,000 |
| 2015/05/29 | 1,616 | 1,625 | 1,569 | 1,569 | -71 | -4.3% | 3,661,000 |
| 2015/05/28 | 1,616 | 1,646 | 1,608 | 1,640 | +26 | +1.6% | 2,021,000 |
| 2015/05/27 | 1,657 | 1,657 | 1,604 | 1,614 | -40 | -2.4% | 2,116,000 |
| 2015/05/26 | 1,658 | 1,660 | 1,645 | 1,654 | -17 | -1% | 1,268,000 |
| 2015/05/25 | 1,680 | 1,681 | 1,663 | 1,671 | +9 | +0.5% | 933,000 |
| 2015/05/22 | 1,681 | 1,685 | 1,658 | 1,662 | -23 | -1.4% | 1,674,000 |
| 2015/05/21 | 1,745 | 1,745 | 1,681 | 1,685 | -64 | -3.7% | 2,245,000 |
| 2015/05/20 | 1,761 | 1,769 | 1,741 | 1,749 | -5 | -0.3% | 1,327,000 |
| 2015/05/19 | 1,778 | 1,778 | 1,744 | 1,754 | -4 | -0.2% | 1,045,000 |
| 2015/05/18 | 1,748 | 1,758 | 1,731 | 1,758 | +20 | +1.2% | 654,000 |
| 2015/05/15 | 1,729 | 1,748 | 1,723 | 1,738 | +24 | +1.4% | 684,000 |
| 2015/05/14 | 1,735 | 1,753 | 1,707 | 1,714 | -38 | -2.2% | 944,000 |
| 2015/05/13 | 1,735 | 1,770 | 1,716 | 1,752 | +34 | +2% | 1,142,000 |
| 2015/05/12 | 1,732 | 1,739 | 1,699 | 1,718 | -4 | -0.2% | 801,000 |
| 2015/05/11 | 1,714 | 1,731 | 1,699 | 1,722 | +48 | +2.9% | 1,190,000 |
| 2015/05/08 | 1,707 | 1,715 | 1,670 | 1,674 | -39 | -2.3% | 1,843,000 |
| 2015/05/07 | 1,755 | 1,762 | 1,706 | 1,713 | -42 | -2.4% | 1,518,000 |
| 2015/05/01 | 1,754 | 1,765 | 1,725 | 1,755 | -1 | -0.1% | 1,286,000 |
2401～
2450
件表示中 / 3698件
類似銘柄と比較する
現在ご覧いただいている「協和キリン」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 協和キリン | 217,400円 | -3.5% | -11.3% | 2.76% | 19.97倍 | 1.34倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
| アステラス薬 | 135,300円 | +0.9% | +380.2% | 5.76% | 18.63倍 | 1.60倍 |
|
医薬品国内２位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
| 塩野義 | 220,700円 | +20.9% | +10.6% | 2.99% | 10.43倍 | 1.38倍 |
|
抗ＨＩＶ薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
| エーザイ | 388,100円 | +1.7% | -2.9% | 4.12% | 25.46倍 | 1.34倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
| 小野薬 | 150,100円 | +0.6% | +43.3% | 5.33% | 10.52倍 | 0.90倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
市場注目の銘柄
チャート関連のコラム
